These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34009698)

  • 1. Cutibacterium acnes: Much ado about maybe nothing much.
    van Steensel MAM; Goh BC
    Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of bacteriophage φPaP11-13 attenuates rat
    Liu Y; Zhen N; Liao D; Niu J; Liu R; Li Z; Lei Z; Yang Z
    Microbiol Spectr; 2024 Feb; 12(2):e0283823. PubMed ID: 38197658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increasing importance of the gut microbiome in acne vulgaris.
    Siddiqui R; Makhlouf Z; Khan NA
    Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphene Attenuates
    Hwang HJ; Kim JE; Lee KW
    J Microbiol Biotechnol; 2022 Nov; 32(11):1390-1395. PubMed ID: 36437519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ
    Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
    Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial toner exhibits bactericidal effect against Cutibacterium acnes via keratin and sebum plug penetration.
    Hamada S; Nakamura Y; Gomi M
    J Microorg Control; 2024; 29(2):63-73. PubMed ID: 38880618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
    Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.